ArticleScientific reports2025
Investigating the protective effects of fullerenol-C60 on kidney and lung tissues in streptozotocin-induced diabetic rats with cecal sepsis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Nanomaterial toxicity and risk assessment integrating functionalization strategies advanced in vitro models and regulatory perspectives.Discover nano · 2026Review
- Effects of fullerenol CExperimental and therapeutic medicine · 2026Article
- Effects of Ozone Therapy on the Bladder of Rats with Streptozocin-Induced Diabetes.Drug design, development and therapy · 2026Article
- Cytotoxicity of Fullerenol CDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the effects of sepsis on distant organs, such as the kidneys and lungs, using an experimental diabetic sepsis model, as well as to explore the role of fullerenol-C60 in these effects. Thirty Wistar rats were divided into four groups: control (group C), diabetes (group D), diabetes sepsis (group DS), and diabetes-sepsis-fullerenol-C60 (group DS-FC60). Diabetes was induced in the diabetes groups by intraperitoneal administration of 55 mg/kg streptozotocin. Rats with blood glucose levels above 250 mg/dL at 72 h were considered diabetic. After 4 weeks, all groups underwent laparotomy under anesthesia. Fullerenol-C60 was administered intraperitoneally at a dose of 100 mg/kg 30 min after the procedure. The sham group was sacrificed 24 h after abdominal incision. In the diabetes group, the abdomen was closed after the incision, and the rats were sacrificed 24 h later. In the DS and DS-FC60 groups, following the abdominal incision, cecal ligation and puncture were performed, the abdomen was closed, and the rats were sacrificed 24 h later. The left kidneys and lungs of the sacrificed rats from all groups were fixed in formalin for histological examination, while the right lungs and kidneys were stored in nitrogen tubes at - 80 °C for biochemical analysis. Vascular vacuolization and hypertrophy, as well as tubular cell degeneration and necrosis, which were observed in the histological evaluation of the kidneys, were significantly lower in group DS-FC60 than in group DS. Similarly, in the biochemical examination of the kidneys, the levels of thiobarbituric acid reactive substances (TBARS) and catalase (CAT) activity were significantly lower in groups DS-FC60 and DS than in group C. In the histological examination of the lungs, neutrophil infiltration/aggregation and the total damage score were significantly lower in group DS-FC60 than in group DS. Significant differences were also observed between groups DS-FC60 and DS in terms of CAT activity and TBARS levels in the biochemical analysis of the lungs. We found that fullerenol-C60, when administered 30 min after sepsis, reduced oxidative stress and improved sepsis-induced damage in the lung and kidney tissues of rats with diabetes mellitus. Our results suggest that fullerenol-C60 administered after sepsis provides protective effects on distant organs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.